Radiotherapy Quality Assurance Program of Ongoing Clinical Trial Using Stereotactic Ablative Radiation Therapy for Recurrent Ovarian Cancer (SABR-ROC): A Dummy Run Study of a Prospective, Randomized, Multicenter Phase III Trial (KGOG 3064/KROG 2204)

Mar 10, 2025·

Sangjoon Park

,

Hojin Kim

,

Chan Woo Wee

,

Young Seok Kim

,

Jin Hwa Choi

,

Yeon Sil Kim

,

Jong Hoon Lee

,

Youngmin Choi

,

Jin Hee Kim

,

Yeona Cho

,

Hyun Ju Kim

,

Young Je Park

,

Won Park

,

Keun-Yong Eom

,

Yun Hwan Kim

,

Yong Bae Kim✉

· 0 min read

Publication

BMC cancer, 25(1), 1336

Last updated on Mar 10, 2026

← Stereotactic body radiotherapy for early-stage non-small cell lung cancer: Comprehensive analysis of outcomes and recurrence from a single-center experience Apr 1, 2025

SegRap2023: A Benchmark of Organs-at-Risk and Gross Tumor Volume Segmentation for Radiotherapy Planning of Nasopharyngeal Carcinoma Jan 2, 2025 →